Compare Intel Corp (INTC) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intel Corp vs Summit Therapeutics Inc — how do they compare? Intel Corp trades at $105.58 (market cap $487.82B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Intel Corp is far larger — about 46.5× Summit Therapeutics Inc's market cap, and Intel Corp pays a 2.24% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| INTC | SMMT | |
|---|---|---|
Market Cap | $487.82B | $10.48B |
Volume | 43,552,012 | — |
Sector | Technology | Health |
52-Week High | $140.94 | $29.32 |
52-Week Low | $19.31 | $13.05 |
Enterprise Value | $500.07B | $9.90B |
Dividend Yield | 2.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
